Insights provides context and perspective about key pharmacy trends and issues

Specialty
AccordantCare offers a range of digital tools that have been proven to improve member engagement and outcomes, as well as a nurse-led care management model that ensures ongoing support and... More
Briefing
Care Management
Prescription Safety Mangement, from CVS Health builds on the success of our opioid management criteria and provides management and safety oversight of all medications across all points of... More
Briefing
A couple stroll together on the beach
Cost Management
In 2019, drug trend for CVS Caremark pharmacy benefit clients was a historically low, industry-leading 1.4 percent, with 41% of clients seeing negative trend. Specialty trend was in the... More
Feature
Cost Management
CVS Health offers payors a new stop-loss program and installment payment plan to help mitigate the large one-time impact of costly gene therapies. These approaches are part of four... More
Briefing
Data analyst sitting at computer
Care Management
There is a lot we don’t know about COVID-19 but data and data analytics can help us better predict the course of the disease, and identify best tools and solutions to help keep members and... More
Commentary
Care Management
CVS Health announces the opening of additional self-swab test sites, making progress toward meeting the goal of 1,000 locations across the country by end of May. More
Commentary
View article
Drug Pipeline
Updates on the robust gene therapy pipeline from CVS Health pipeline team to help payors stay abreast of this very important emerging category. More
Briefing
Care Management
Accordant is using technology, digital tools to provide nurses the most up-to-date information so they can help members who have pandemic-related, condition management concerns. More
Commentary
Care Management
Chief Medical Officer Sree Chaguturu offers perspective on clinical terms in the news and considerations for a coronavirus vaccine. More
Commentary
Drug Pipeline
After many years of failure, there is hope for potential treatments that could slow disease progression for those with Alzheimer's Disease. If approved, Biogen's aducanumab will... More
Feature